Hallucinations Under Psychedelics and in the Schizophrenia Spectrum: An Interdisciplinary and Multiscale Comparison.


Journal

Schizophrenia bulletin
ISSN: 1745-1701
Titre abrégé: Schizophr Bull
Pays: United States
ID NLM: 0236760

Informations de publication

Date de publication:
01 12 2020
Historique:
pubmed: 19 9 2020
medline: 26 10 2021
entrez: 18 9 2020
Statut: ppublish

Résumé

The recent renaissance of psychedelic science has reignited interest in the similarity of drug-induced experiences to those more commonly observed in psychiatric contexts such as the schizophrenia-spectrum. This report from a multidisciplinary working group of the International Consortium on Hallucinations Research (ICHR) addresses this issue, putting special emphasis on hallucinatory experiences. We review evidence collected at different scales of understanding, from pharmacology to brain-imaging, phenomenology and anthropology, highlighting similarities and differences between hallucinations under psychedelics and in the schizophrenia-spectrum disorders. Finally, we attempt to integrate these findings using computational approaches and conclude with recommendations for future research.

Identifiants

pubmed: 32944778
pii: 5908041
doi: 10.1093/schbul/sbaa117
pmc: PMC7707069
doi:

Substances chimiques

Hallucinogens 0

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1396-1408

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center.

Références

Neuroimage. 2020 Apr 1;209:116462
pubmed: 31857204
Pharmacol Rev. 2019 Jul;71(3):316-344
pubmed: 31221820
Neuropsychopharmacology. 2001 Oct;25(4):565-75
pubmed: 11557170
Psychiatry Res. 2017 Jun;252:154-160
pubmed: 28273630
Neuropsychopharmacology. 2019 Jun;44(7):1328-1334
pubmed: 30685771
J Psychopharmacol. 2008 Aug;22(6):621-32
pubmed: 18593735
J Psychopharmacol. 2008 Aug;22(6):603-20
pubmed: 18593734
Curr Top Behav Neurosci. 2018;36:257-282
pubmed: 27900674
Brain Imaging Behav. 2020 Feb;14(1):186-199
pubmed: 30382529
Life Sci. 1984 Dec 17;35(25):2505-11
pubmed: 6513725
Acta Psychiatr Scand. 2017 Dec;136(6):648-657
pubmed: 28940312
Schizophr Bull. 2014 Jul;40 Suppl 4:S246-54
pubmed: 24903416
Brain Cogn. 2017 Mar;112:92-97
pubmed: 26809759
Proc Natl Acad Sci U S A. 2019 Feb 12;116(7):2743-2748
pubmed: 30692255
Trends Cogn Sci. 2012 Jan;16(1):72-80
pubmed: 22177032
Science. 2017 Aug 11;357(6351):596-600
pubmed: 28798131
Eur J Pharmacol. 1983 Jul 22;91(2-3):189-96
pubmed: 6617740
Front Psychol. 2013 Oct 17;4:753
pubmed: 24146659
Schizophr Bull. 2014 Jul;40 Suppl 4:S213-20
pubmed: 24936082
Schizophr Bull. 2014 Jul;40 Suppl 4:S233-45
pubmed: 24936084
Hum Brain Mapp. 2016 Jul;37(7):2571-86
pubmed: 27016153
J Pharmacol Exp Ther. 1995 Apr;273(1):101-12
pubmed: 7714755
Proc Natl Acad Sci U S A. 2016 Apr 26;113(17):4853-8
pubmed: 27071089
Cereb Cortex. 2013 May;23(5):1108-17
pubmed: 22535908
Front Neurosci. 2018 Jan 22;12:7
pubmed: 29403350
Brain. 2008 Dec;131(Pt 12):3169-77
pubmed: 18854323
Ann N Y Acad Sci. 1957 Mar 14;66(3):418-34
pubmed: 13425232
Schizophr Bull. 2016 Sep;42(5):1110-23
pubmed: 27280452
Schizophr Res. 2017 Feb;180:70-77
pubmed: 27784534
Front Physiol. 2020 Feb 11;11:66
pubmed: 32116776
Neuroimage. 2014 Feb 1;86:343-53
pubmed: 24128734
Trends Cogn Sci. 2011 Oct;15(10):483-506
pubmed: 21908230
Neurol Sci. 2019 Feb;40(2):339-349
pubmed: 30448966
Psychopharmacology (Berl). 2018 Feb;235(2):505-519
pubmed: 29396616
Curr Biol. 2017 Feb 6;27(3):451-457
pubmed: 28132813
AMA Arch Gen Psychiatry. 1959 Jul;1:58-69
pubmed: 13842570
Sci Rep. 2019 Nov 19;9(1):16324
pubmed: 31745107
Neural Comput. 2017 Jan;29(1):1-49
pubmed: 27870614
J Psychopharmacol. 2011 Nov;25(11):1434-52
pubmed: 20855349
Br J Psychiatry. 1994 Feb;164(2):190-201
pubmed: 8173822
Cereb Cortex. 2014 Dec;24(12):3116-30
pubmed: 23825317
Psychopharmacology (Berl). 2005 Sep;181(3):496-503
pubmed: 15983786
PLoS Comput Biol. 2008 Nov;4(11):e1000211
pubmed: 18989391
Neuroreport. 1998 Dec 1;9(17):3897-902
pubmed: 9875725
Neurosci Biobehav Rev. 2016 Oct;69:113-23
pubmed: 27473935
Nat Commun. 2020 Jan 16;11(1):325
pubmed: 31949140
Sci Rep. 2016 Dec 01;6:38152
pubmed: 27905557
Schizophr Bull. 2013 Nov;39(6):1343-51
pubmed: 23044373
Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):13040-5
pubmed: 19620724
Philos Trans R Soc Lond B Biol Sci. 2009 May 12;364(1521):1211-21
pubmed: 19528002
Cereb Cortex. 2018 Feb 1;28(2):726-737
pubmed: 29161362
Neuron. 2007 Feb 1;53(3):439-52
pubmed: 17270739
Trends Cogn Sci. 2006 Jul;10(7):287-91
pubmed: 16807064
Am J Psychiatry. 2011 Jan;168(1):73-81
pubmed: 20952459
Psychopharmacology (Berl). 2017 Jul;234(13):2031-2046
pubmed: 28386699
Br J Psychiatry. 2015 Jan;206(1):41-4
pubmed: 24970772
Schizophr Bull. 2020 Aug 09;:
pubmed: 32772114
Lancet Psychiatry. 2014 Jul;1(2):148-58
pubmed: 26360579
Schizophr Res. 2016 Oct;176(2-3):493-499
pubmed: 27349814
Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9673-8
pubmed: 15976020
J Psychopharmacol. 2018 Jul;32(7):725-731
pubmed: 29446697
Neurosci Lett. 1985 Sep 30;60(2):207-13
pubmed: 2997677
Drug Test Anal. 2012 Jul-Aug;4(7-8):556-76
pubmed: 22517680
Compr Psychiatry. 2011 May-Jun;52(3):319-25
pubmed: 21497227
Elife. 2018 Oct 25;7:
pubmed: 30355445
Psychol Med. 1996 Jan;26(1):177-89
pubmed: 8643757
Brain. 2013 Nov;136(Pt 11):3227-41
pubmed: 24065721
Pharmacol Biochem Behav. 1985 Sep;23(3):461-8
pubmed: 4048241
Annu Rev Neurosci. 2015 Jul 8;38:433-47
pubmed: 25938726
Neuropharmacology. 2016 Aug;107:364-375
pubmed: 27020041
Acta Psychiatr Scand. 1990 Jul;82(1):26-9
pubmed: 2399817
Psychopharmacology (Berl). 2009 Nov;206(4):515-30
pubmed: 19475401
J Psychopharmacol. 2016 Dec;30(12):1259-1267
pubmed: 27852960
J Affect Disord. 2017 Dec 1;223:106-114
pubmed: 28743059
PLoS One. 2013 Aug 19;8(8):e63972
pubmed: 23976938
Behav Pharmacol. 2003 Dec;14(8):599-607
pubmed: 14665977
PLoS One. 2012;7(2):e30800
pubmed: 22363492
Eur Psychiatry. 2017 Mar;41:122-128
pubmed: 28142106
Curr Opin Neurobiol. 2017 Oct;46:154-161
pubmed: 28915387
Schizophr Bull. 2012 Jun;38(4):683-93
pubmed: 22446568
Curr Top Behav Neurosci. 2018;36:393-430
pubmed: 28401522
Hum Brain Mapp. 2017 Oct;38(10):4966-4979
pubmed: 28660668
Psychopharmacology (Berl). 2013 Jun;227(4):727-39
pubmed: 23407781
Neuropsychopharmacology. 1998 May;18(5):339-51
pubmed: 9536447
Acta Psychiatr Scand. 2006 Oct;114(4):290-2; discussion 292
pubmed: 16968367
Behav Pharmacol. 2006 Feb;17(1):51-9
pubmed: 16377963
Biol Psychiatry. 2018 Nov 1;84(9):634-643
pubmed: 30007575
Comput Psychiatr. 2018 Dec;2:183-204
pubmed: 30627670
Schizophr Bull. 1990;16(3):425-32
pubmed: 1981107
Behav Brain Sci. 2013 Jun;36(3):181-204
pubmed: 23663408
Schizophr Bull. 2007 Jul;33(4):994-1003
pubmed: 17493957
Brain Struct Funct. 2010 Jun;214(5-6):655-67
pubmed: 20512370
Schizophr Res. 2017 Feb;180:58-63
pubmed: 27531067
J Psychiatry Neurosci. 2012 Jan;37(1):17-27
pubmed: 21693094
Trends Cogn Sci. 2019 Feb;23(2):114-127
pubmed: 30583945
Neurosci Conscious. 2020 Jun 12;2020(1):niaa007
pubmed: 32550008
Br J Psychiatry. 2012 Sep;201(3):215-20
pubmed: 22743843
Schizophr Bull. 2012 May;38(3):475-85
pubmed: 20841326
J Neurophysiol. 2009 Jun;101(6):3270-83
pubmed: 19339462
Nat Neurosci. 2000 Nov;3 Suppl:1212-7
pubmed: 11127840
Psychiatry Res. 2018 Nov;269:25-30
pubmed: 30145297
PLoS Comput Biol. 2020 Apr 23;16(4):e1007805
pubmed: 32324758
Biol Psychiatry. 2011 Mar 1;69(5):399-406
pubmed: 21126732
Nat Commun. 2017 Jan 31;8:14218
pubmed: 28139642
Biol Psychiatry. 2020 Jul 15;88(2):197-207
pubmed: 32111343
Front Hum Neurosci. 2013 Oct 30;7:727
pubmed: 24198777
Proc Natl Acad Sci U S A. 2012 Feb 7;109(6):2138-43
pubmed: 22308440
Neuropharmacology. 2020 May 1;167:107933
pubmed: 31917152
Curr Top Behav Neurosci. 2018;36:313-332
pubmed: 28444578
Psychopathology. 2008;41(6):346-55
pubmed: 18765960
Psychol Med Monogr Suppl. 1992;20:1-97
pubmed: 1565705
Psychopharmacology (Berl). 2010 Feb;208(2):179-89
pubmed: 19937319
Psychopharmacology (Berl). 1990;100(3):417-25
pubmed: 2138338

Auteurs

Pantelis Leptourgos (P)

Department of Psychiatry, Connecticut Mental Health Center, Yale University, New Haven, CT.

Martin Fortier-Davy (M)

Institut Jean Nicod, École des Hautes Études en Sciences Sociales, École Normale Supérieure, PSL Research University, Paris France.

Robin Carhart-Harris (R)

Imperial College London, London, UK.

Philip R Corlett (PR)

Department of Psychiatry, Connecticut Mental Health Center, Yale University, New Haven, CT.

David Dupuis (D)

Department of Anthropology, University of Durham, Durham, UK.

Adam L Halberstadt (AL)

Department of Psychiatry, University of California San Diego, La Jolla, CA.
Research Service, VA San Diego Healthcare System, San Diego, CA.

Michael Kometer (M)

Pharmaco-Neuroimaging and Cognitive-Emotional Processing, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Eva Kozakova (E)

Department of Applied Neurosciences and Brain Imaging, National Institute of Mental Health, Klecany, Czechia.
Department of Psychology, Faculty of Arts, Charles University, Prague, Czechia.

Frank LarØi (F)

Department of Biological and Medical Psychology, Faculty of Psychology, University of Bergen, Bergen, Norway.
Psychology and Neuroscience of Cognition Research Unit, University of Liège, Liège, Belgium.
Norwegian Center of Excellence for Mental Disorders Research, University of Oslo, Oslo, Norway.

Tehseen N Noorani (TN)

Department of Anthropology, University of Durham, Durham, UK.

Katrin H Preller (KH)

Pharmaco-Neuroimaging and Cognitive-Emotional Processing, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Flavie Waters (F)

School of Psychological Sciences, The University of Western Australia, Perth, Western Australia.

Yuliya Zaytseva (Y)

Department of Applied Neurosciences and Brain Imaging, National Institute of Mental Health, Klecany, Czechia.
Department of Psychiatry and Medical Psychology, 3rd Faculty of Medicine, Charles University in Prague, Prague, Czechia.

Renaud Jardri (R)

Univ. Lille, INSERM U1172, CHU Lille, Lille Neuroscience & Cognition Centre (LiNC), Plasticity & SubjectivitY team, Lille, France.
Laboratoire de Neurosciences Cognitives et Computationnelles, ENS, INSERM U960, PSL Research University, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH